3652 results for «348»

Filter By

3652 results

Transcatheter management of structural defects

20 May 2025 – From EuroPCR 2025

Explore the transcatheter management of structural cardiac defects with challenging clinical scenarios including ventricular septal ruptures and post-TAVI complications. This session emphasizes multidisciplinary approaches and strategic planning to avert catastrophic outcomes and optimize patient care.

Transcatheter management of structural defects

Supraflex for high-risk patients and lesions: from practice to evidence-based medicine proven through FIRE and COMPARE

20 May 2025 – From EuroPCR 2025

Discover the latest evidence on the Supraflex thin-strut sirolimus DES in complex cases—from small vessels and diabetes to STEMI—supported by OCT analysis. This session highlights Supraflex’s performance in high bleeding risk and elderly patients, featuring data from FIRE, COMPARE, EARTH HBR, and Cruz Senior studies. Get...

Supraflex for high-risk patients and lesions: from practice to evidence-based medicine proven through FIRE and COMPARE

Techniques for the treatment of left main lesions

20 May 2025 – From EuroPCR 2025

Discover contemporary techniques for treating left main coronary artery lesions with a focus on ultra low-contrast PCI, management of calcified Medina 0-0-1 lesions, and troubleshooting intravascular lithotripsy. This session provides practical insights into complex lesion treatment to enhance safety and efficacy.

Techniques for the treatment of left main lesions

Symplicity Spyral renal denervation: more insights from clinical practice

21 May 2025 – From EuroPCR 2025

Renal denervation is gaining momentum in the management of hypertension. This EuroPCR 2025 session brings together long-term clinical experience and practical guidance on using the Symplicity Spyral™ system. Learn how to apply the latest European guidelines in daily practice, pick up valuable procedural tips from over...

Symplicity Spyral renal denervation: more insights from clinical practice

Invasive treatment of refractory angina

20 May 2025 – From EuroPCR 2025

Explore invasive treatment options for refractory angina through clinical case presentations emphasizing coronary physiology guidance, coronary microvascular disease management, and innovative therapies such as coronary sinus reducer implantation. This session highlights provocative test-guided approaches to optimize patient outcomes.

Invasive treatment of refractory angina

The future is now: QFR and RMS to optimise coronary artery disease patient management

20 May 2025 – From EuroPCR 2025

See how next-generation technologies are reshaping coronary artery disease treatment in this EuroPCR 2025 session. Learn how QFR is being used to plan PCI and evaluate results, and discover new insights into RMS technology—offering a potential leap beyond traditional drug-eluting stents. From practical case experience to...

The future is now: QFR and RMS to optimise coronary artery disease patient management

Nurses and allied professionals abstracts session

20 May 2025 – From EuroPCR 2025

Highlight the pivotal role of nurses and allied health professionals in interventional cardiology through a series of abstracts addressing radial haemostasis, TAVI nursing programs, early mobilization, radiation protection, and physiologist-led intracoronary thermodilution assessments.

Nurses and allied professionals abstracts session

Key principles of successful large bore vascular access and closure: TAVI and beyond

21 May 2025 – From EuroPCR 2025

This session explores suture-mediated vascular closure techniques, particularly for TAVI and large-bore venous access.  

Through real-world clinical case, speakers highlight the value of ultrasound and CT imaging for precise puncture planning and complication avoidance.  

Detailed steps for arterial closure with ProGlide device are provided, with technical...

Key principles of successful large bore vascular access and closure: TAVI and beyond

Transcatheter management of failed THV - LIVE case

09 Feb 2025 – From PCR Tokyo Valves 2025

An 84-year-old woman with diabetes mellitus, frailty (5/6), preserved LV function, and aortic stenosis previously treated with CoreValve 26 mm in 2016, presented with symptomatic degenerative stenosis of the valve.
A Sapien 3 (23 mm) was implanted without predilatation but with post-dilatation under general anaesthesia, using cerebral...

Transcatheter management of failed THV - LIVE case

COVID-19: Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

07 Jan 2021

Examination of the study methodology and results according to the PICOT principle, SWOT analysis and real-world applicability

COVID-19: Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

The CLEAR SYNERGY (OASIS 9) Trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone versus placebo in patients with myocardial infarction

18 Nov 2024

Mirvat Alasnag provides her take on the CLEAR SYNERGY trial presented by Sanjit S Jolly at AHA 2024 in Chicago.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
CLEAR SYNERGY

Top Interventional Trials presented at ACC.21

07 Jun 2021

Ali Nazmi Calik provides a summary and key take-aways and infographics of 9 major trials of interest to interventional cardiologists presented at ACC.21

Ali Nazmi Calik

Author

Ali Nazmi Calik
Top Interventional Trials presented at ACC.21
Didn’t find what you were looking for?